Deletion of graft reactive cells by idarubicin-anti-CD8 (Ly-2.1) immunoconjugate: studies in the mouse heart graft model.
作者信息
Mottram P L, Pietersz G A, Purcell L J, Krauer K, Clunie G J, McKenzie I F
机构信息
Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.
出版信息
Transplant Proc. 1991 Feb;23(1 Pt 1):499-500.
PMID:1899311
Abstract
摘要
相似文献
1
Deletion of graft reactive cells by idarubicin-anti-CD8 (Ly-2.1) immunoconjugate: studies in the mouse heart graft model.
Transplant Proc. 1991 Feb;23(1 Pt 1):499-500.
2
Immunosuppression by anti-CD8 (Ly-2.1) MAb conjugated to idarubicin: studies in the mouse heart graft model.
Transplant Proc. 1990 Oct;22(5):2111-2.
3
Anti-T cell-specific immunoconjugates in mice: in vivo effects.
Transplant Proc. 1989 Oct;21(5):3757-8.
4
Tolerance induction with anti-CD8 monoclonal antibodies in the mouse heart transplant model.
Transplant Proc. 1993 Oct;25(5):2935-6.
5
Immunosuppression by aminopterin or idarubicin conjugated to anti-CD8 in the mouse heart allograft model.
Transplant Proc. 1992 Oct;24(5):2301.
6
Evidence that an anthracycline-anti-CD8 immunoconjugate, idarubicin-anti-Ly-2.1, prolongs heart allograft survival in mice.
Transplantation. 1993 Mar;55(3):484-90. doi: 10.1097/00007890-199303000-00006.
7
Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
Transplant Proc. 1993 Feb;25(1 Pt 1):792-3.
8
Distribution of Ly-6C on lymphocyte subsets: I. Influence of allotype on T lymphocyte expression.
J Immunol. 1997 May 1;158(9):4211-22.
9
Generation and regeneration of a novel anti-CD8-resistant cytolytic T lymphocyte population.
Cell Immunol. 2000 Oct 10;205(1):1-12. doi: 10.1006/cimm.2000.1709.
10
Effects of anti-L3T4 and anti-LYT2 monoclonal antibody therapy on cardiac allograft survival in presensitized recipients.
Transplant Proc. 1989 Feb;21(1 Pt 1):1022.
Zotero 插件